APO Research
Talk to an analyst

APO RESEARCH · REPORT

Artificial Intelligence in Biotechnology

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Artificial Intelligence in Biotechnology Market Analysis and Forecast 2026-2032

4 July 2026190 pages

Choose your research edition.

Industry ResearchArtificial Intelligence in Biotechnology Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Artificial Intelligence in Biotechnology Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Artificial Intelligence in Biotechnology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Artificial Intelligence in Biotechnology Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Artificial Intelligence in Biotechnology Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Artificial Intelligence in Biotechnology market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Artificial Intelligence in Biotechnology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Artificial Intelligence in Biotechnology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Artificial Intelligence in Biotechnology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Artificial Intelligence in Biotechnology is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Artificial Intelligence in Biotechnology include AstraZeneca, Thales Group, IBM Corp., ForeSee Medical, Atomwise, Cloud Pharmaceuticals, GNS Healthcare, Microsoft Corporation and Novartis AG, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Artificial Intelligence in Biotechnology, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Artificial Intelligence in Biotechnology, also provides the revenue of main regions and countries. Of the upcoming market potential for Artificial Intelligence in Biotechnology, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Artificial Intelligence in Biotechnology revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Artificial Intelligence in Biotechnology market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Artificial Intelligence in Biotechnology revenue, projected growth trends, production technology, application and end-user industry.

Artificial Intelligence in Biotechnology Segment by Company

AstraZeneca

Thales Group

IBM Corp.

ForeSee Medical

Atomwise

Cloud Pharmaceuticals

GNS Healthcare

Microsoft Corporation

Novartis AG

NVIDIA Corporation

Pfizer

Recursion Pharmaceuticals

XtalPi Inc

Aidoc

AliveCor

GE Healthcare

Imagen Technologies

Vuno Inc.

IDx Technologies Inc.

Siemens Healthcare GmbH

Neural Analytics

Artificial Intelligence in Biotechnology Segment by Type

Hardware

Software

Artificial Intelligence in Biotechnology Segment by Application

Healthcare and Medicine

Agriculture

Industrial Biotechnology

Environmental Biotechnology

Food and Beverage Industry

Others

Artificial Intelligence in Biotechnology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Artificial Intelligence in Biotechnology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Artificial Intelligence in Biotechnology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Artificial Intelligence in Biotechnology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Artificial Intelligence in Biotechnology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Artificial Intelligence in Biotechnology company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Intelligence in Biotechnology revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Artificial Intelligence in Biotechnology Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Hardware Major Player Table 3. Software Major Player Table 4. Global Artificial Intelligence in Biotechnology Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Healthcare and Medicine Major Player Table 6. Agriculture Major Player Table 7. Industrial Biotechnology Major Player Table 8. Environmental Biotechnology Major Player Table 9. Food and Beverage Industry Major Player Table 10. Others Major Player Table 11. Artificial Intelligence in Biotechnology Industry Trends Table 12. Artificial Intelligence in Biotechnology Industry Drivers Table 13. Artificial Intelligence in Biotechnology Industry Opportunities and Challenges Table 14. Artificial Intelligence in Biotechnology Industry Restraints Table 15. Global Artificial Intelligence in Biotechnology Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Artificial Intelligence in Biotechnology Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Artificial Intelligence in Biotechnology Market Share by Region (2021-2026) Table 18. Global Artificial Intelligence in Biotechnology Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Artificial Intelligence in Biotechnology Market Share by Region (2027-2032) Table 20. Global Artificial Intelligence in Biotechnology Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Artificial Intelligence in Biotechnology Revenue Market Share by Players (2021-2026) Table 22. Global Artificial Intelligence in Biotechnology Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Artificial Intelligence in Biotechnology Key Players Headquarters & Area Served Table 24. Global Artificial Intelligence in Biotechnology Players, Product Type & Application Table 25. Global Artificial Intelligence in Biotechnology Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Artificial Intelligence in Biotechnology by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Artificial Intelligence in Biotechnology Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Artificial Intelligence in Biotechnology Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Artificial Intelligence in Biotechnology Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Artificial Intelligence in Biotechnology Revenue Market Share by Type (2021-2026) Table 32. Global Artificial Intelligence in Biotechnology Revenue Market Share by Type (2027-2032) Table 33. Global Artificial Intelligence in Biotechnology Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Artificial Intelligence in Biotechnology Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Artificial Intelligence in Biotechnology Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Artificial Intelligence in Biotechnology Revenue Market Share by Application (2021-2026) Table 37. Global Artificial Intelligence in Biotechnology Revenue Market Share by Application (2027-2032) Table 38. AstraZeneca Company Information Table 39. AstraZeneca Business Overview Table 40. AstraZeneca Artificial Intelligence in Biotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. AstraZeneca Artificial Intelligence in Biotechnology Product Portfolio Table 42. AstraZeneca Recent Development Table 43. Thales Group Company Information Table 44. Thales Group Business Overview Table 45. Thales Group Artificial Intelligence in Biotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Thales Group Artificial Intelligence in Biotechnology Product Portfolio Table 47. Thales Group Recent Development Table 48. IBM Corp. Company Information Table 49. IBM Corp. Business Overview Table 50. IBM Corp. Artificial Intelligence in Biotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. IBM Corp. Artificial Intelligence in Biotechnology Product Portfolio Table 52. IBM Corp. Recent Development Table 53. ForeSee Medical Company Information Table 54. ForeSee Medical Business Overview Table 55. ForeSee Medical Artificial Intelligence in Biotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. ForeSee Medical Artificial Intelligence in Biotechnology Product Portfolio Table 57. ForeSee Medical Recent Development Table 58. Atomwise Company Information Table 59. Atomwise Business Overview Table 60. Atomwise Artificial Intelligence in Biotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Atomwise Artificial Intelligence in Biotechnology Product Portfolio Table 62. Atomwise Recent Development Table 63. Cloud Pharmaceuticals Company Information Table 64. Cloud Pharmaceuticals Business Overview Table 65. Cloud Pharmaceuticals Artificial Intelligence in Biotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Cloud Pharmaceuticals Artificial Intelligence in Biotechnology Product Portfolio Table 67. Cloud Pharmaceuticals Recent Development Table 68. GNS Healthcare Company Information Table 69. GNS Healthcare Business Overview Table 70. GNS Healthcare Artificial Intelligence in Biotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. GNS Healthcare Artificial Intelligence in Biotechnology Product Portfolio Table 72. GNS Healthcare Recent Development Table 73. Microsoft Corporation Company Information Table 74. Microsoft Corporation Business Overview Table 75. Microsoft Corporation Artificial Intelligence in Biotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Microsoft Corporation Artificial Intelligence in Biotechnology Product Portfolio Table 77. Microsoft Corporation Recent Development Table 78. Novartis AG Company Information Table 79. Novartis AG Business Overview Table 80. Novartis AG Artificial Intelligence in Biotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Novartis AG Artificial Intelligence in Biotechnology Product Portfolio Table 82. Novartis AG Recent Development Table 83. NVIDIA Corporation Company Information Table 84. NVIDIA Corporation Business Overview Table 85. NVIDIA Corporation Artificial Intelligence in Biotechnology Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. NVIDIA Corporation Artificial Intelligence in Biotechnology Product Portfolio Table 87. NVIDIA Corporation Recent Development Table 88. Pfizer Company Information Table 89. Pfizer Business Overview Table 90. Pfizer Artificial Intelligence in Biotechnology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Pfizer Artificial Intelligence in Biotechnology Product Portfolio Table 92. Pfizer Recent Development Table 93. Recursion Pharmaceuticals Company Information Table 94. Recursion Pharmaceuticals Business Overview Table 95. Recursion Pharmaceuticals Artificial Intelligence in Biotechnology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Recursion Pharmaceuticals Artificial Intelligence in Biotechnology Product Portfolio Table 97. Recursion Pharmaceuticals Recent Development Table 98. XtalPi Inc Company Information Table 99. XtalPi Inc Business Overview Table 100. XtalPi Inc Artificial Intelligence in Biotechnology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. XtalPi Inc Artificial Intelligence in Biotechnology Product Portfolio Table 102. XtalPi Inc Recent Development Table 103. Aidoc Company Information Table 104. Aidoc Business Overview Table 105. Aidoc Artificial Intelligence in Biotechnology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Aidoc Artificial Intelligence in Biotechnology Product Portfolio Table 107. Aidoc Recent Development Table 108. AliveCor Company Information Table 109. AliveCor Business Overview Table 110. AliveCor Artificial Intelligence in Biotechnology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. AliveCor Artificial Intelligence in Biotechnology Product Portfolio Table 112. AliveCor Recent Development Table 113. GE Healthcare Company Information Table 114. GE Healthcare Business Overview Table 115. GE Healthcare Artificial Intelligence in Biotechnology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. GE Healthcare Artificial Intelligence in Biotechnology Product Portfolio Table 117. GE Healthcare Recent Development Table 118. Imagen Technologies Company Information Table 119. Imagen Technologies Business Overview Table 120. Imagen Technologies Artificial Intelligence in Biotechnology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Imagen Technologies Artificial Intelligence in Biotechnology Product Portfolio Table 122. Imagen Technologies Recent Development Table 123. Vuno Inc. Company Information Table 124. Vuno Inc. Business Overview Table 125. Vuno Inc. Artificial Intelligence in Biotechnology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Vuno Inc. Artificial Intelligence in Biotechnology Product Portfolio Table 127. Vuno Inc. Recent Development Table 128. IDx Technologies Inc. Company Information Table 129. IDx Technologies Inc. Business Overview Table 130. IDx Technologies Inc. Artificial Intelligence in Biotechnology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. IDx Technologies Inc. Artificial Intelligence in Biotechnology Product Portfolio Table 132. IDx Technologies Inc. Recent Development Table 133. Siemens Healthcare GmbH Company Information Table 134. Siemens Healthcare GmbH Business Overview Table 135. Siemens Healthcare GmbH Artificial Intelligence in Biotechnology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Siemens Healthcare GmbH Artificial Intelligence in Biotechnology Product Portfolio Table 137. Siemens Healthcare GmbH Recent Development Table 138. Neural Analytics Company Information Table 139. Neural Analytics Business Overview Table 140. Neural Analytics Artificial Intelligence in Biotechnology Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Neural Analytics Artificial Intelligence in Biotechnology Product Portfolio Table 142. Neural Analytics Recent Development Table 143. North America Artificial Intelligence in Biotechnology Revenue by Type (2021-2026) & (US$ Million) Table 144. North America Artificial Intelligence in Biotechnology Revenue by Type (2027-2032) & (US$ Million) Table 145. North America Artificial Intelligence in Biotechnology Revenue by Application (2021-2026) & (US$ Million) Table 146. North America Artificial Intelligence in Biotechnology Revenue by Application (2027-2032) & (US$ Million) Table 147. North America Artificial Intelligence in Biotechnology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 148. North America Artificial Intelligence in Biotechnology Revenue by Country (2021-2026) & (US$ Million) Table 149. North America Artificial Intelligence in Biotechnology Revenue by Country (US$ Million) & (2027-2032) Table 150. Europe Artificial Intelligence in Biotechnology Revenue by Type (2021-2026) & (US$ Million) Table 151. Europe Artificial Intelligence in Biotechnology Revenue by Type (2027-2032) & (US$ Million) Table 152. Europe Artificial Intelligence in Biotechnology Revenue by Application (2021-2026) & (US$ Million) Table 153. Europe Artificial Intelligence in Biotechnology Revenue by Application (2027-2032) & (US$ Million) Table 154. Europe Artificial Intelligence in Biotechnology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. Europe Artificial Intelligence in Biotechnology Revenue by Country (2021-2026) & (US$ Million) Table 156. Europe Artificial Intelligence in Biotechnology Revenue by Country (US$ Million) & (2027-2032) Table 157. China Artificial Intelligence in Biotechnology Revenue by Type (2021-2026) & (US$ Million) Table 158. China Artificial Intelligence in Biotechnology Revenue by Type (2027-2032) & (US$ Million) Table 159. China Artificial Intelligence in Biotechnology Revenue by Application (2021-2026) & (US$ Million) Table 160. China Artificial Intelligence in Biotechnology Revenue by Application (2027-2032) & (US$ Million) Table 161. Asia Artificial Intelligence in Biotechnology Revenue by Type (2021-2026) & (US$ Million) Table 162. Asia Artificial Intelligence in Biotechnology Revenue by Type (2027-2032) & (US$ Million) Table 163. Asia Artificial Intelligence in Biotechnology Revenue by Application (2021-2026) & (US$ Million) Table 164. Asia Artificial Intelligence in Biotechnology Revenue by Application (2027-2032) & (US$ Million) Table 165. Asia Artificial Intelligence in Biotechnology Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 166. Asia Artificial Intelligence in Biotechnology Revenue by Region (US$ Million) & (2021-2026) Table 167. Asia Artificial Intelligence in Biotechnology Revenue by Region (US$ Million) & (2027-2032) Table 168. SAMEA Artificial Intelligence in Biotechnology Revenue by Type (2021-2026) & (US$ Million) Table 169. SAMEA Artificial Intelligence in Biotechnology Revenue by Type (2027-2032) & (US$ Million) Table 170. SAMEA Artificial Intelligence in Biotechnology Revenue by Application (2021-2026) & (US$ Million) Table 171. SAMEA Artificial Intelligence in Biotechnology Revenue by Application (2027-2032) & (US$ Million) Table 172. SAMEA Artificial Intelligence in Biotechnology Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. SAMEA Artificial Intelligence in Biotechnology Revenue by Country (2021-2026) & (US$ Million) Table 174. SAMEA Artificial Intelligence in Biotechnology Revenue by Country (US$ Million) & (2027-2032) Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Artificial Intelligence in Biotechnology Image Figure 2. Global Artificial Intelligence in Biotechnology Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Artificial Intelligence in Biotechnology Market Size Share 2021 VS 2025 VS 2032 Figure 4. Hardware Image Figure 5. Software Image Figure 6. Global Artificial Intelligence in Biotechnology Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Artificial Intelligence in Biotechnology Market Size Share 2021 VS 2025 VS 2032 Figure 8. Healthcare and Medicine Image Figure 9. Agriculture Image Figure 10. Industrial Biotechnology Image Figure 11. Environmental Biotechnology Image Figure 12. Food and Beverage Industry Image Figure 13. Others Image Figure 14. Global Artificial Intelligence in Biotechnology Market Size (US$ Million) & (2021-2032) Figure 15. Global Artificial Intelligence in Biotechnology Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Artificial Intelligence in Biotechnology Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Artificial Intelligence in Biotechnology Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Artificial Intelligence in Biotechnology Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Artificial Intelligence in Biotechnology Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Artificial Intelligence in Biotechnology Revenue Market Share by Type (2021-2032) Figure 22. Global Artificial Intelligence in Biotechnology Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Artificial Intelligence in Biotechnology Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Artificial Intelligence in Biotechnology Revenue Market Share by Application (2021-2032) Figure 25. North America Artificial Intelligence in Biotechnology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Artificial Intelligence in Biotechnology Revenue Share by Type (2021-2032) Figure 27. North America Artificial Intelligence in Biotechnology Revenue Share by Application (2021-2032) Figure 28. North America Artificial Intelligence in Biotechnology Revenue Share by Country (2021-2032) Figure 29. United States Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Artificial Intelligence in Biotechnology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Artificial Intelligence in Biotechnology Revenue Share by Type (2021-2032) Figure 34. Europe Artificial Intelligence in Biotechnology Revenue Share by Application (2021-2032) Figure 35. Europe Artificial Intelligence in Biotechnology Revenue Share by Country (2021-2032) Figure 36. Germany Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Artificial Intelligence in Biotechnology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Artificial Intelligence in Biotechnology Revenue Share by Type (2021-2032) Figure 46. China Artificial Intelligence in Biotechnology Revenue Share by Application (2021-2032) Figure 47. Asia Artificial Intelligence in Biotechnology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Artificial Intelligence in Biotechnology Revenue Share by Type (2021-2032) Figure 49. Asia Artificial Intelligence in Biotechnology Revenue Share by Application (2021-2032) Figure 50. Asia Artificial Intelligence in Biotechnology Revenue Share by Region (2021-2032) Figure 51. Japan Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Artificial Intelligence in Biotechnology Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Artificial Intelligence in Biotechnology Revenue Share by Type (2021-2032) Figure 59. SAMEA Artificial Intelligence in Biotechnology Revenue Share by Application (2021-2032) Figure 60. SAMEA Artificial Intelligence in Biotechnology Revenue Share by Country (2021-2032) Figure 61. Brazil Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Artificial Intelligence in Biotechnology Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Hardware
  • Software
Applications
  • Healthcare and Medicine
  • Agriculture
  • Industrial Biotechnology
  • Environmental Biotechnology
  • Food and Beverage Industry
  • Others
Companies covered
  • AstraZeneca
  • Thales Group
  • IBM Corp.
  • ForeSee Medical
  • Atomwise
  • Cloud Pharmaceuticals
  • GNS Healthcare
  • Microsoft Corporation
  • Novartis AG
  • NVIDIA Corporation
  • Pfizer
  • Recursion Pharmaceuticals
  • XtalPi Inc
  • Aidoc
  • AliveCor
  • GE Healthcare
  • Imagen Technologies
  • Vuno Inc.
  • IDx Technologies Inc.
  • Siemens Healthcare GmbH
  • Neural Analytics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Artificial Intelligence in Biotechnology Market by Type
  3. 1.2.1 Global Artificial Intelligence in Biotechnology Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Hardware
  5. 1.2.3 Software
  6. 1.3 Artificial Intelligence in Biotechnology Market by Application
  7. 1.3.1 Global Artificial Intelligence in Biotechnology Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Healthcare and Medicine
  9. 1.3.3 Agriculture
  10. 1.3.4 Industrial Biotechnology
  11. 1.3.5 Environmental Biotechnology
  12. 1.3.6 Food and Beverage Industry
  13. 1.3.7 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Artificial Intelligence in Biotechnology Market Dynamics
  1. 2.1 Artificial Intelligence in Biotechnology Industry Trends
  2. 2.2 Artificial Intelligence in Biotechnology Industry Drivers
  3. 2.3 Artificial Intelligence in Biotechnology Industry Opportunities and Challenges
  4. 2.4 Artificial Intelligence in Biotechnology Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Artificial Intelligence in Biotechnology Market Perspective (2021-2032)
  2. 3.2 Global Artificial Intelligence in Biotechnology Growth Trends by Region
  3. 3.2.1 Global Artificial Intelligence in Biotechnology Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Artificial Intelligence in Biotechnology Market Size by Region (2021-2026)
  5. 3.2.3 Global Artificial Intelligence in Biotechnology Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Artificial Intelligence in Biotechnology Revenue by Players
  2. 4.1.1 Global Artificial Intelligence in Biotechnology Revenue by Players (2021-2026)
  3. 4.1.2 Global Artificial Intelligence in Biotechnology Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Artificial Intelligence in Biotechnology Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Artificial Intelligence in Biotechnology Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Artificial Intelligence in Biotechnology Key Players Headquarters & Area Served
  7. 4.4 Global Artificial Intelligence in Biotechnology Players, Product Type & Application
  8. 4.5 Global Artificial Intelligence in Biotechnology Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Artificial Intelligence in Biotechnology Market CR5 and HHI
  11. 4.6.3 2025 Artificial Intelligence in Biotechnology Tier 1, Tier 2, and Tier 3
5 Artificial Intelligence in Biotechnology Market Size by Type
  1. 5.1 Global Artificial Intelligence in Biotechnology Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Artificial Intelligence in Biotechnology Revenue by Type (2021-2032)
  3. 5.3 Global Artificial Intelligence in Biotechnology Revenue Market Share by Type (2021-2032)
6 Artificial Intelligence in Biotechnology Market Size by Application
  1. 6.1 Global Artificial Intelligence in Biotechnology Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Artificial Intelligence in Biotechnology Revenue by Application (2021-2032)
  3. 6.3 Global Artificial Intelligence in Biotechnology Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 AstraZeneca
  2. 7.1.1 AstraZeneca Company Information
  3. 7.1.2 AstraZeneca Business Overview
  4. 7.1.3 AstraZeneca Artificial Intelligence in Biotechnology Revenue and Gross Margin (2021-2026)
  5. 7.1.4 AstraZeneca Artificial Intelligence in Biotechnology Product Portfolio
  6. 7.1.5 AstraZeneca Recent Developments
  7. 7.2 Thales Group
  8. 7.2.1 Thales Group Company Information
  9. 7.2.2 Thales Group Business Overview
  10. 7.2.3 Thales Group Artificial Intelligence in Biotechnology Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Thales Group Artificial Intelligence in Biotechnology Product Portfolio
  12. 7.2.5 Thales Group Recent Developments
  13. 7.3 IBM Corp.
  14. 7.3.1 IBM Corp. Company Information
  15. 7.3.2 IBM Corp. Business Overview
  16. 7.3.3 IBM Corp. Artificial Intelligence in Biotechnology Revenue and Gross Margin (2021-2026)
  17. 7.3.4 IBM Corp. Artificial Intelligence in Biotechnology Product Portfolio
  18. 7.3.5 IBM Corp. Recent Developments
  19. 7.4 ForeSee Medical
  20. 7.4.1 ForeSee Medical Company Information
  21. 7.4.2 ForeSee Medical Business Overview
  22. 7.4.3 ForeSee Medical Artificial Intelligence in Biotechnology Revenue and Gross Margin (2021-2026)
  23. 7.4.4 ForeSee Medical Artificial Intelligence in Biotechnology Product Portfolio
  24. 7.4.5 ForeSee Medical Recent Developments
  25. 7.5 Atomwise
  26. 7.5.1 Atomwise Company Information
  27. 7.5.2 Atomwise Business Overview
  28. 7.5.3 Atomwise Artificial Intelligence in Biotechnology Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Atomwise Artificial Intelligence in Biotechnology Product Portfolio
  30. 7.5.5 Atomwise Recent Developments
  31. 7.6 Cloud Pharmaceuticals
  32. 7.6.1 Cloud Pharmaceuticals Company Information
  33. 7.6.2 Cloud Pharmaceuticals Business Overview
  34. 7.6.3 Cloud Pharmaceuticals Artificial Intelligence in Biotechnology Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Cloud Pharmaceuticals Artificial Intelligence in Biotechnology Product Portfolio
  36. 7.6.5 Cloud Pharmaceuticals Recent Developments
  37. 7.7 GNS Healthcare
  38. 7.7.1 GNS Healthcare Company Information
  39. 7.7.2 GNS Healthcare Business Overview
  40. 7.7.3 GNS Healthcare Artificial Intelligence in Biotechnology Revenue and Gross Margin (2021-2026)
  41. 7.7.4 GNS Healthcare Artificial Intelligence in Biotechnology Product Portfolio
  42. 7.7.5 GNS Healthcare Recent Developments
  43. 7.8 Microsoft Corporation
  44. 7.8.1 Microsoft Corporation Company Information
  45. 7.8.2 Microsoft Corporation Business Overview
  46. 7.8.3 Microsoft Corporation Artificial Intelligence in Biotechnology Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Microsoft Corporation Artificial Intelligence in Biotechnology Product Portfolio
  48. 7.8.5 Microsoft Corporation Recent Developments
  49. 7.9 Novartis AG
  50. 7.9.1 Novartis AG Company Information
  51. 7.9.2 Novartis AG Business Overview
  52. 7.9.3 Novartis AG Artificial Intelligence in Biotechnology Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Novartis AG Artificial Intelligence in Biotechnology Product Portfolio
  54. 7.9.5 Novartis AG Recent Developments
  55. 7.10 NVIDIA Corporation
  56. 7.10.1 NVIDIA Corporation Company Information
  57. 7.10.2 NVIDIA Corporation Business Overview
  58. 7.10.3 NVIDIA Corporation Artificial Intelligence in Biotechnology Revenue and Gross Margin (2021-2026)
  59. 7.10.4 NVIDIA Corporation Artificial Intelligence in Biotechnology Product Portfolio
  60. 7.10.5 NVIDIA Corporation Recent Developments
  61. 7.11 Pfizer
  62. 7.11.1 Pfizer Company Information
  63. 7.11.2 Pfizer Business Overview
  64. 7.11.3 Pfizer Artificial Intelligence in Biotechnology Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Pfizer Artificial Intelligence in Biotechnology Product Portfolio
  66. 7.11.5 Pfizer Recent Developments
  67. 7.12 Recursion Pharmaceuticals
  68. 7.12.1 Recursion Pharmaceuticals Company Information
  69. 7.12.2 Recursion Pharmaceuticals Business Overview
  70. 7.12.3 Recursion Pharmaceuticals Artificial Intelligence in Biotechnology Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Recursion Pharmaceuticals Artificial Intelligence in Biotechnology Product Portfolio
  72. 7.12.5 Recursion Pharmaceuticals Recent Developments
  73. 7.13 XtalPi Inc
  74. 7.13.1 XtalPi Inc Company Information
  75. 7.13.2 XtalPi Inc Business Overview
  76. 7.13.3 XtalPi Inc Artificial Intelligence in Biotechnology Revenue and Gross Margin (2021-2026)
  77. 7.13.4 XtalPi Inc Artificial Intelligence in Biotechnology Product Portfolio
  78. 7.13.5 XtalPi Inc Recent Developments
  79. 7.14 Aidoc
  80. 7.14.1 Aidoc Company Information
  81. 7.14.2 Aidoc Business Overview
  82. 7.14.3 Aidoc Artificial Intelligence in Biotechnology Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Aidoc Artificial Intelligence in Biotechnology Product Portfolio
  84. 7.14.5 Aidoc Recent Developments
  85. 7.15 AliveCor
  86. 7.15.1 AliveCor Company Information
  87. 7.15.2 AliveCor Business Overview
  88. 7.15.3 AliveCor Artificial Intelligence in Biotechnology Revenue and Gross Margin (2021-2026)
  89. 7.15.4 AliveCor Artificial Intelligence in Biotechnology Product Portfolio
  90. 7.15.5 AliveCor Recent Developments
  91. 7.16 GE Healthcare
  92. 7.16.1 GE Healthcare Company Information
  93. 7.16.2 GE Healthcare Business Overview
  94. 7.16.3 GE Healthcare Artificial Intelligence in Biotechnology Revenue and Gross Margin (2021-2026)
  95. 7.16.4 GE Healthcare Artificial Intelligence in Biotechnology Product Portfolio
  96. 7.16.5 GE Healthcare Recent Developments
  97. 7.17 Imagen Technologies
  98. 7.17.1 Imagen Technologies Company Information
  99. 7.17.2 Imagen Technologies Business Overview
  100. 7.17.3 Imagen Technologies Artificial Intelligence in Biotechnology Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Imagen Technologies Artificial Intelligence in Biotechnology Product Portfolio
  102. 7.17.5 Imagen Technologies Recent Developments
  103. 7.18 Vuno Inc.
  104. 7.18.1 Vuno Inc. Company Information
  105. 7.18.2 Vuno Inc. Business Overview
  106. 7.18.3 Vuno Inc. Artificial Intelligence in Biotechnology Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Vuno Inc. Artificial Intelligence in Biotechnology Product Portfolio
  108. 7.18.5 Vuno Inc. Recent Developments
  109. 7.19 IDx Technologies Inc.
  110. 7.19.1 IDx Technologies Inc. Company Information
  111. 7.19.2 IDx Technologies Inc. Business Overview
  112. 7.19.3 IDx Technologies Inc. Artificial Intelligence in Biotechnology Revenue and Gross Margin (2021-2026)
  113. 7.19.4 IDx Technologies Inc. Artificial Intelligence in Biotechnology Product Portfolio
  114. 7.19.5 IDx Technologies Inc. Recent Developments
  115. 7.20 Siemens Healthcare GmbH
  116. 7.20.1 Siemens Healthcare GmbH Company Information
  117. 7.20.2 Siemens Healthcare GmbH Business Overview
  118. 7.20.3 Siemens Healthcare GmbH Artificial Intelligence in Biotechnology Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Siemens Healthcare GmbH Artificial Intelligence in Biotechnology Product Portfolio
  120. 7.20.5 Siemens Healthcare GmbH Recent Developments
  121. 7.21 Neural Analytics
  122. 7.21.1 Neural Analytics Company Information
  123. 7.21.2 Neural Analytics Business Overview
  124. 7.21.3 Neural Analytics Artificial Intelligence in Biotechnology Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Neural Analytics Artificial Intelligence in Biotechnology Product Portfolio
  126. 7.21.5 Neural Analytics Recent Developments
8 North America
  1. 8.1 North America Artificial Intelligence in Biotechnology Revenue (2021-2032)
  2. 8.2 North America Artificial Intelligence in Biotechnology Revenue by Type (2021-2032)
  3. 8.2.1 North America Artificial Intelligence in Biotechnology Revenue by Type (2021-2026)
  4. 8.2.2 North America Artificial Intelligence in Biotechnology Revenue by Type (2027-2032)
  5. 8.3 North America Artificial Intelligence in Biotechnology Revenue Share by Type (2021-2032)
  6. 8.4 North America Artificial Intelligence in Biotechnology Revenue by Application (2021-2032)
  7. 8.4.1 North America Artificial Intelligence in Biotechnology Revenue by Application (2021-2026)
  8. 8.4.2 North America Artificial Intelligence in Biotechnology Revenue by Application (2027-2032)
  9. 8.5 North America Artificial Intelligence in Biotechnology Revenue Share by Application (2021-2032)
  10. 8.6 North America Artificial Intelligence in Biotechnology Revenue by Country
  11. 8.6.1 North America Artificial Intelligence in Biotechnology Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Artificial Intelligence in Biotechnology Revenue by Country (2021-2026)
  13. 8.6.3 North America Artificial Intelligence in Biotechnology Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Artificial Intelligence in Biotechnology Revenue (2021-2032)
  2. 9.2 Europe Artificial Intelligence in Biotechnology Revenue by Type (2021-2032)
  3. 9.2.1 Europe Artificial Intelligence in Biotechnology Revenue by Type (2021-2026)
  4. 9.2.2 Europe Artificial Intelligence in Biotechnology Revenue by Type (2027-2032)
  5. 9.3 Europe Artificial Intelligence in Biotechnology Revenue Share by Type (2021-2032)
  6. 9.4 Europe Artificial Intelligence in Biotechnology Revenue by Application (2021-2032)
  7. 9.4.1 Europe Artificial Intelligence in Biotechnology Revenue by Application (2021-2026)
  8. 9.4.2 Europe Artificial Intelligence in Biotechnology Revenue by Application (2027-2032)
  9. 9.5 Europe Artificial Intelligence in Biotechnology Revenue Share by Application (2021-2032)
  10. 9.6 Europe Artificial Intelligence in Biotechnology Revenue by Country
  11. 9.6.1 Europe Artificial Intelligence in Biotechnology Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Artificial Intelligence in Biotechnology Revenue by Country (2021-2026)
  13. 9.6.3 Europe Artificial Intelligence in Biotechnology Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Artificial Intelligence in Biotechnology Revenue (2021-2032)
  2. 10.2 China Artificial Intelligence in Biotechnology Revenue by Type (2021-2032)
  3. 10.2.1 China Artificial Intelligence in Biotechnology Revenue by Type (2021-2026)
  4. 10.2.2 China Artificial Intelligence in Biotechnology Revenue by Type (2027-2032)
  5. 10.3 China Artificial Intelligence in Biotechnology Revenue Share by Type (2021-2032)
  6. 10.4 China Artificial Intelligence in Biotechnology Revenue by Application (2021-2032)
  7. 10.4.1 China Artificial Intelligence in Biotechnology Revenue by Application (2021-2026)
  8. 10.4.2 China Artificial Intelligence in Biotechnology Revenue by Application (2027-2032)
  9. 10.5 China Artificial Intelligence in Biotechnology Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Artificial Intelligence in Biotechnology Revenue (2021-2032)
  2. 11.2 Asia Artificial Intelligence in Biotechnology Revenue by Type (2021-2032)
  3. 11.2.1 Asia Artificial Intelligence in Biotechnology Revenue by Type (2021-2026)
  4. 11.2.2 Asia Artificial Intelligence in Biotechnology Revenue by Type (2027-2032)
  5. 11.3 Asia Artificial Intelligence in Biotechnology Revenue Share by Type (2021-2032)
  6. 11.4 Asia Artificial Intelligence in Biotechnology Revenue by Application (2021-2032)
  7. 11.4.1 Asia Artificial Intelligence in Biotechnology Revenue by Application (2021-2026)
  8. 11.4.2 Asia Artificial Intelligence in Biotechnology Revenue by Application (2027-2032)
  9. 11.5 Asia Artificial Intelligence in Biotechnology Revenue Share by Application (2021-2032)
  10. 11.6 Asia Artificial Intelligence in Biotechnology Revenue by Country
  11. 11.6.1 Asia Artificial Intelligence in Biotechnology Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Artificial Intelligence in Biotechnology Revenue by Country (2021-2026)
  13. 11.6.3 Asia Artificial Intelligence in Biotechnology Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Artificial Intelligence in Biotechnology Revenue (2021-2032)
  2. 12.2 SAMEA Artificial Intelligence in Biotechnology Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Artificial Intelligence in Biotechnology Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Artificial Intelligence in Biotechnology Revenue by Type (2027-2032)
  5. 12.3 SAMEA Artificial Intelligence in Biotechnology Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Artificial Intelligence in Biotechnology Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Artificial Intelligence in Biotechnology Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Artificial Intelligence in Biotechnology Revenue by Application (2027-2032)
  9. 12.5 SAMEA Artificial Intelligence in Biotechnology Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Artificial Intelligence in Biotechnology Revenue by Country
  11. 12.6.1 SAMEA Artificial Intelligence in Biotechnology Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Artificial Intelligence in Biotechnology Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Artificial Intelligence in Biotechnology Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst